Entrada Therapeutics Ownership & Insider Activity - Benzinga

Entrada Therapeutics Inc

TRDANASDAQ

Trade with Public

Trade with Public

$4.59

-0.14-2.96%

Dern. MÀJ: Oct 23, 9:40 AM

Aperçu Actualités Prévisions de résultats Événements Objectifs de cours Données financières SentimentActionnariatComparer Options Rapport sur les stocks

Entrada Therapeutics Ownership & Insider Activity - Benzinga

Entrada Therapeutics Ownership & Insider Activity

Entrada Therapeutics (TRDA) institutional and insider ownership, recent insider transactions and ownership breakdown.

Net Insider Activity by Month

Purchases (90d)

0

Sales (90d)

12

$10.3M total

Net Activity

Net Selling

Net Value (90d)

-$10.3M

Entrada Therapeutics Insider Transactions (Last 6 Months)

Voir toutes les transactions d'initiés →

Date	Insider	Title	Type	Shares	Price	Value
Sep 4, 2026	MPM BIOVENTURES LP, MPM BioVentures LLC, MPM BioVentures GP LLC	10% OWNER	SELL	259.837K	$7.33	$1.9M
Sep 4, 2026	MPM BioVentures LP, LUKE EVNIN, ANSBERT GADICKE, Todd Foley, MPM BioVentures B LP, MPM Asset Management Investors BV LLC, MPM BioVentures LLC, MPM BioVentures GP LLC, MPM BIOVENTURES B LP, MPM ASSET MANAGEMENT INVESTORS BV LLC	10% OWNER	SELL	259.837K	$7.33	$1.9M
Sep 1, 2026	MPM BIOVENTURES LP, MPM BioVentures LLC, MPM BioVentures GP LLC	10% OWNER	SELL	86.482K	$7.14	$617K
Sep 1, 2026	MPM BioVentures LP, LUKE EVNIN, ANSBERT GADICKE, Todd Foley, MPM BioVentures B LP, MPM Asset Management Investors BV LLC, MPM BioVentures LLC, MPM BioVentures GP LLC, MPM BIOVENTURES B LP, MPM ASSET MANAGEMENT INVESTORS BV LLC	10% OWNER	SELL	86.482K	$7.14	$617K
Aug 27, 2026	MPM BIOVENTURES LP, MPM BioVentures LLC, MPM BioVentures GP LLC	10% OWNER	SELL	86.914K	$7.08	$616K
Aug 27, 2026	MPM BioVentures LP, LUKE EVNIN, ANSBERT GADICKE, Todd Foley, MPM BioVentures B LP, MPM Asset Management Investors BV LLC, MPM BioVentures LLC, MPM BioVentures GP LLC, MPM BIOVENTURES B LP, MPM ASSET MANAGEMENT INVESTORS BV LLC	10% OWNER	SELL	86.914K	$7.08	$616K
Aug 24, 2026	MPM BioVentures LP, LUKE EVNIN, ANSBERT GADICKE, Todd Foley, MPM BioVentures B LP, MPM Asset Management Investors BV LLC, MPM BioVentures LLC, MPM BioVentures GP LLC, MPM BIOVENTURES B LP, MPM ASSET MANAGEMENT INVESTORS BV LLC	10% OWNER	SELL	62.714K	$7.36	$462K
Aug 24, 2026	MPM BIOVENTURES LP, MPM BioVentures LLC, MPM BioVentures GP LLC	10% OWNER	SELL	62.714K	$7.36	$462K
Aug 6, 2026	Kush Parmar	—	SELL	155.255K	$6.95	$1.1M
Aug 6, 2026	AM Ventures V LP, AM Partners V LLC, AM Opportunities I LP, AM Opportunities I GP LLC, SCOTT ROCKLAGE, Andrew Schwab	10% OWNER	SELL	62.811K	$6.88	$432K
Jul 30, 2026	AM Ventures V LP, AM Partners V LLC, AM Opportunities I LP, AM Opportunities I GP LLC, SCOTT ROCKLAGE, Andrew Schwab	10% OWNER	SELL	116.474K	$6.93	$807K
Jul 30, 2026	Kush Parmar	—	SELL	116.474K	$6.93	$807K
May 20, 2026	Bernhardt Zeiher	DIRECTOR	BUY	5.000K	$5.86	$29K
May 4, 2026	Natarajan Sethuraman	PRESIDENT, RESEARCH & DEVELOP.	SELL	25.907K	$15.39	$399K
May 4, 2026	Nathan Dowden	PRESIDENT & COO	SELL-OPTIONS	—	$8.54	$204K